Literature DB >> 12140376

Protein kinase C isoforms in normal and transformed cells of the melanocytic lineage.

E Selzer1, I Okamoto, T Lucas, R Kodym, H Pehamberger, B Jansen.   

Abstract

Enzymes belonging to the protein kinase C (PKC) family represent one of the major mediators of signal transduction in melanocytes. To identify PKC isoforms that may be associated with the process of malignant transformation and metastasis, we investigated the expression pattern of 11 different PKC isoforms (alpha, beta I, beta II, gamma, delta, epsilon, eta, theta, zeta, lambda, and iota) in melanoma lymph node metastases, in cell lines established from these metastases, in primary cell cultures from normal melanocytes, and in permanent cell lines established from spontaneously transformed melanocytes. PKC alpha, beta I, beta II, delta, epsilon, eta, zeta, lambda and iota were found to be expressed in total lysates from melanoma metastases. In permanent cell lines established from these metastases, the expression levels of PKC beta I, beta II, delta, epsilon, and eta were lower or undetectable when compared with initial expression in tumour lysates. In normal primary melanocyte cultures, the PKC isoforms beta II, delta, epsilon, eta and iota were undetectable. PKC gamma and theta isoforms were undetectable in all melanocytic cell types examined. PKC iota was the only isoform exclusively detected in tumour lysates, in spontaneously transformed melanoma cells and melanoma cell lines, but not in normal melanocytes, and may therefore be associated with the transformed phenotype in human melanoma in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140376     DOI: 10.1097/00008390-200206000-00003

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  16 in total

1.  RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma.

Authors:  Xu Chen; Qiuxia Wu; Philippe Depeille; Peirong Chen; Sophie Thornton; Helen Kalirai; Sarah E Coupland; Jeroen P Roose; Boris C Bastian
Journal:  Cancer Cell       Date:  2017-05-08       Impact factor: 31.743

2.  NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop.

Authors:  Jie Shen; Lijun Xu; Taofeek K Owonikoko; Shi-Yong Sun; Fadlo R Khuri; Walter J Curran; Xingming Deng
Journal:  Cancer Lett       Date:  2011-12-13       Impact factor: 8.679

3.  Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors.

Authors:  Elaine M Reno; James M Haughian; Irina K Dimitrova; Twila A Jackson; Kenneth R Shroyer; Andrew P Bradford
Journal:  Hum Pathol       Date:  2007-10-24       Impact factor: 3.466

4.  Role of BMP-4 and Its Signaling Pathways in Cultured Human Melanocytes.

Authors:  Hee-Young Park; Christina Wu; Mina Yaar; Christina M Stachur; Marita Kosmadaki; Barbara A Gilchrest
Journal:  Int J Cell Biol       Date:  2009-12-30

5.  Rewired ERK-JNK signaling pathways in melanoma.

Authors:  Pablo Lopez-Bergami; Conway Huang; James S Goydos; Dana Yip; Menashe Bar-Eli; Meenhard Herlyn; Keiran S M Smalley; Alka Mahale; Alexey Eroshkin; Stuart Aaronson; Ze'ev Ronai
Journal:  Cancer Cell       Date:  2007-05       Impact factor: 31.743

6.  Involvement of PKC-iota in glioma proliferation.

Authors:  R Patel; H Win; S Desai; K Patel; J A Matthews; M Acevedo-Duncan
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

7.  Clinical relevance of neutral endopeptidase (NEP/CD10) in melanoma.

Authors:  Elsa F Velazquez; Molly Yancovitz; Anna Pavlick; Russell Berman; Richard Shapiro; Dusan Bogunovic; David O'Neill; Yi-Lo Yu; Joanna Spira; Paul J Christos; Xi Kathy Zhou; Madhu Mazumdar; David M Nanus; Leonard Liebes; Nina Bhardwaj; David Polsky; Iman Osman
Journal:  J Transl Med       Date:  2007-01-05       Impact factor: 5.531

8.  The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study.

Authors:  M J Millward; C House; D Bowtell; L Webster; I N Olver; M Gore; M Copeman; K Lynch; A Yap; Y Wang; P S Cohen; J Zalcberg
Journal:  Br J Cancer       Date:  2006-09-12       Impact factor: 7.640

Review 9.  Putative role of natural products as Protein Kinase C modulator in different disease conditions.

Authors:  Rishi Kant Singh; Sanjay Kumar; Munendra Singh Tomar; Praveen Kumar Verma; Amit Kumar; Sandeep Kumar; Naveen Kumar; Jai Prakash Singh; Arbind Acharya
Journal:  Daru       Date:  2021-07-03       Impact factor: 4.088

10.  Src, PKCalpha, and PKCdelta are required for alphavbeta3 integrin-mediated metastatic melanoma invasion.

Authors:  Andrew J Putnam; Veronique V Schulz; Eric M Freiter; Heather M Bill; Cindy K Miranti
Journal:  Cell Commun Signal       Date:  2009-04-28       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.